Evidence map›Paper›PMID 41409567›Full record

ArticleACS applied nano materials2025

Zero-Valent Iron Nanocatalysts via Polymers or Metal Hydroxide Passivation: Implications for Advanced Oxidation Processes.

Carlos Díaz-Ufano, Nahuel Nuñez, Alvaro Gallo-Cordova, Elin L Winkler, María Del Puerto Morales, Sabino Veintemillas-Verdaguer

Abstract read
In one paragraph

Article in ACS applied nano materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Engineered ZnACS applied nano materials · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlos Díaz-UfanoDepartamento de Nanociencia y Nanotecnología, Instituto de Ciencia de Materiales de Madrid, ICMM/CSIC, C/Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID https://orcid.org/0000-0002-3287-5325
Nahuel NuñezEscuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autónoma de Madrid. C/Francisco Tomás y Valiente, 28049 Madrid, Spain.ORCID https://orcid.org/0009-0008-5669-4490
Alvaro Gallo-CordovaDepartamento de Nanociencia y Nanotecnología, Instituto de Ciencia de Materiales de Madrid, ICMM/CSIC, C/Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID https://orcid.org/0000-0001-5140-9162
Elin L WinklerGerencia de Física, Laboratorio de Resonancias Magnéticas, Centro Atómico Bariloche, Av. Bustillo 9500, 8400 San Carlos de Bariloche, Río Negro, Argentina.
María Del Puerto MoralesDepartamento de Nanociencia y Nanotecnología, Instituto de Ciencia de Materiales de Madrid, ICMM/CSIC, C/Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID https://orcid.org/0000-0002-7290-7029
Sabino Veintemillas-VerdaguerDepartamento de Nanociencia y Nanotecnología, Instituto de Ciencia de Materiales de Madrid, ICMM/CSIC, C/Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID https://orcid.org/0000-0002-3015-1470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zero-valent iron (ZVI) nanocatalysts are promising materials for environmental remediation (e.g., wastewater treatment) via advanced oxidation processes (AOPs) due to their ability to generate reactive oxygen species (ROS). However, their high reactivity often leads to rapid surface oxidation and a limited stability. This study evaluates the effect of different surface coatings on the stability and ROS production of ZVI nanocatalysts. The coatings tested include organic molecules such as mannitol and polyvinylpyrrolidone (PVP), as well as combinations with thin layers of metal hydroxides (M-(OH)

Indexed as

coatingFenton-like catalysisreactive oxygen speciesstabilityzero-valent iron

Identifiers

PMID41409567
PMCPMC12706743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.